Genesis HealthCare (GEN) Reports In-Line Q4 Loss
Genesis HealthCare (NYSE: GEN) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.42 billion.
For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.
